Effects of Spousal Participation in Breastfeeding Interventions at Different Perinatal Stages on Mothers' Coparenting Cognition and Infant Feeding Patterns

March 4, 2026 updated by: Run Huang, Sichuan University

The Effects of Spousal Participation in Breastfeeding Interventions at Different Perinatal Stages on Mothers' Coparenting Cognition and Infant Feeding Patterns: A Prospective Quasi-Experimental Study

Problem: While partner support benefits breastfeeding outcomes, its impact across perinatal stages on maternal co-parenting perception is unclear.

Background: Spousal involvement plays a vital role in successful breastfeeding and maternal well-being.

Aim: This study aimed to examine the effects of spousal participation in breastfeeding interventions at different perinatal stages on maternal co-parenting perceptions and infant feeding practices for full-term infants.

Methods: Pregnant women who received antenatal care and delivered at our hospital, together with their partners, were recruited and categorized by the timing of partner involvement in breastfeeding activities: both antenatal and postnatal (Group A); antenatal only (Group B); postnatal only (Group C); and no antenatal education but routine postnatal guidance (Group D). Maternal breastfeeding self-efficacy and coparenting perception were assessed at 6, 12, and 24 weeks postpartum.

Study Overview

Study Type

Interventional

Enrollment (Actual)

526

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shaanxi
      • Xi'an, Shaanxi, China, 710061
        • Northwest Women's and Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Married couples, with gestational age between 12 - 14 weeks at enrollment for Groups A and B;
  • Planned discharge within 48 hours after delivery;
  • Mothers and partners expected to cohabit for ≥6 months postpartum;
  • Gestational age at delivery ≥37 weeks;
  • No diagnosed psychiatric disorders in either partner;
  • Voluntary participation with written informed consent from both mother and partner;
  • Neonates with Apgar scores ≥8 at 1, 5, and 10 minutes after birth.

Exclusion Criteria:

  • Maternal diagnosis of infectious diseases (e.g., HIV, hepatitis B);
  • Withdrawal from the study at any stage;
  • Failure to complete required questionnaires;
  • Loss to follow-up during the study period;
  • Concurrent participation in other interventional studies;
  • Major fetal anomalies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Full-stage Parental Involvement Group (A)
Perinatal (14 weeks gestation to 24 weeks postpartum) parental joint breastfeeding support
Multistage breastfeeding support involving fathers: prenatal education (14-37 weeks gestation, including manuals and videos), intrapartum 'three early' practices (skin-to-skin contact, early suckling, early milk initiation), and postpartum follow-up (48 hours to 24 weeks, including activity records, QR code resources, and weekly follow-up).
Experimental: Prenatal Parental Involvement Group (B)
Prenatal (14 weeks gestation to delivery) parental joint breastfeeding support, postpartum maternal-only support
Multistage breastfeeding support involving fathers: prenatal education (14-37 weeks gestation, including manuals and videos), intrapartum 'three early' practices (skin-to-skin contact, early suckling, early milk initiation), and postpartum follow-up (48 hours to 24 weeks, including activity records, QR code resources, and weekly follow-up).
Experimental: Postpartum Parental Involvement Group (C)
Prenatal maternal-only support, postpartum (delivery to 24 weeks) parental joint breastfeeding support
Multistage breastfeeding support involving fathers: prenatal education (14-37 weeks gestation, including manuals and videos), intrapartum 'three early' practices (skin-to-skin contact, early suckling, early milk initiation), and postpartum follow-up (48 hours to 24 weeks, including activity records, QR code resources, and weekly follow-up).
Active Comparator: Maternal-only Support Group (D)
Postpartum maternal-only routine breastfeeding guidance
Routine postpartum breastfeeding guidance provided only to mothers (no paternal involvement), including basic breastfeeding skill training and regular follow-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal Breastfeeding Self-Efficacy
Time Frame: 6 weeks postpartum, 12 weeks postpartum, 24 weeks postpartum
Measured by the Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF). This 14-item scale uses a 5-point response scale (1 = not confident at all, 5 = completely confident), with a total score ranging from 14 to 70. Higher scores indicate stronger breastfeeding self-efficacy. Measured at 6, 12, and 24 weeks postpartum.
6 weeks postpartum, 12 weeks postpartum, 24 weeks postpartum
Spousal Involvement Frequency in Breastfeeding
Time Frame: 6 weeks postpartum; 12 weeks postpartum; 24 weeks postpartum
Recorded via a self-designed activity log, including spousal assistance in breastfeeding preparation, positioning, and follow-up.
6 weeks postpartum; 12 weeks postpartum; 24 weeks postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Coparenting Perception Level
Time Frame: 6 weeks postpartum; 12 weeks postpartum; 24 weeks postpartum
Measured by the Brief Coparenting Relationship Scale (Brief-CRS). This 14-item scale uses a 6-point response scale (0 = completely disagree, 6 = completely agree), with a total score ranging from 0 to 84. Higher scores indicate better coparenting coordination between parents. Measured at 6, 12, and 24 weeks postpartum.
6 weeks postpartum; 12 weeks postpartum; 24 weeks postpartum
Breastfeeding Type
Time Frame: 6 weeks postpartum; 12 weeks postpartum; 24 weeks postpartum
Categorized as exclusive breastfeeding, mixed feeding, or formula feeding, based on maternal self-report.
6 weeks postpartum; 12 weeks postpartum; 24 weeks postpartum
Neonatal Weight Gain
Time Frame: 6 weeks postpartum; 12 weeks postpartum; 24 weeks postpartum
Recorded as the change in neonatal body weight (in kilograms) from birth to each follow-up time point, based on clinical follow-up records.
6 weeks postpartum; 12 weeks postpartum; 24 weeks postpartum
Duration of Jaundice
Time Frame: 6 weeks postpartum; 12 weeks postpartum; 24 weeks postpartum
Recorded as the number of days from the onset of neonatal jaundice to its complete resolution, based on clinical follow-up records.
6 weeks postpartum; 12 weeks postpartum; 24 weeks postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 20, 2020

Primary Completion (Actual)

October 20, 2020

Study Completion (Actual)

October 20, 2020

Study Registration Dates

First Submitted

February 2, 2026

First Submitted That Met QC Criteria

March 4, 2026

First Posted (Actual)

March 10, 2026

Study Record Updates

Last Update Posted (Actual)

March 10, 2026

Last Update Submitted That Met QC Criteria

March 4, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20-078

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Feeding

Clinical Trials on Parental Involvement in Breastfeeding Support

Subscribe